JP2022550640A5 - - Google Patents
Info
- Publication number
- JP2022550640A5 JP2022550640A5 JP2022546587A JP2022546587A JP2022550640A5 JP 2022550640 A5 JP2022550640 A5 JP 2022550640A5 JP 2022546587 A JP2022546587 A JP 2022546587A JP 2022546587 A JP2022546587 A JP 2022546587A JP 2022550640 A5 JP2022550640 A5 JP 2022550640A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- occurrence
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025136895A JP2025186255A (ja) | 2019-10-07 | 2025-08-20 | Ｋｖ１．３カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962911670P | 2019-10-07 | 2019-10-07 | |
| US62/911,670 | 2019-10-07 | ||
| PCT/US2020/054347 WO2021071802A1 (en) | 2019-10-07 | 2020-10-06 | Aryl heterocyclic compounds as kv1.3 potassium shaker channel blockers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025136895A Division JP2025186255A (ja) | 2019-10-07 | 2025-08-20 | Ｋｖ１．３カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022550640A JP2022550640A (ja) | 2022-12-02 |
| JP2022550640A5 true JP2022550640A5 (enExample) | 2024-09-10 |
Family
ID=75438323
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022546587A Withdrawn JP2022550640A (ja) | 2019-10-07 | 2020-10-06 | Ｋｖ１．３カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物 |
| JP2025136895A Pending JP2025186255A (ja) | 2019-10-07 | 2025-08-20 | Ｋｖ１．３カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025136895A Pending JP2025186255A (ja) | 2019-10-07 | 2025-08-20 | Ｋｖ１．３カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230026611A1 (enExample) |
| EP (1) | EP4041407A4 (enExample) |
| JP (2) | JP2022550640A (enExample) |
| KR (1) | KR20220079882A (enExample) |
| CN (1) | CN114746151A (enExample) |
| AU (1) | AU2020362108A1 (enExample) |
| BR (1) | BR112022006202A2 (enExample) |
| CA (1) | CA3156980A1 (enExample) |
| IL (1) | IL291868A (enExample) |
| MX (1) | MX2022004127A (enExample) |
| WO (1) | WO2021071802A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023003841A (es) | 2020-10-06 | 2023-06-23 | De Shaw Res Llc | Compuestos lactámicos como bloqueadores del canal agitador de potasio kv1.3. |
| KR20230164136A (ko) * | 2021-03-30 | 2023-12-01 | 디.이. 쇼우 리서치, 엘엘씨 | Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로시클릭 화합물 |
| EP4351569A4 (en) * | 2021-05-28 | 2025-04-16 | D.E. Shaw Research, LLC | Spiroindolinone compounds as kv1.3 potassium shaker channel blockers |
| CN113637002B (zh) * | 2021-08-02 | 2022-09-30 | 天津太平洋化学制药有限公司 | 一种尼拉帕尼的制备方法 |
| CN113603573A (zh) * | 2021-08-09 | 2021-11-05 | 苏州求索生物科技有限公司 | 一种3,5-二氯-2-碘苯甲醚的制备工艺 |
| CN114213315A (zh) * | 2021-12-31 | 2022-03-22 | 上海陶术生物科技有限公司 | 含氮杂环类化合物及其中间体的合成方法 |
| CN114524800A (zh) * | 2022-01-20 | 2022-05-24 | 上海陶术生物科技有限公司 | 尼拉帕尼中间体的合成方法 |
| WO2024088343A1 (zh) * | 2022-10-28 | 2024-05-02 | 上海深势唯思科技有限责任公司 | 一种芳基杂环类Kv1.3抑制剂及其制备方法和用途 |
| WO2025021167A1 (zh) * | 2023-07-26 | 2025-01-30 | 上海汇伦医药股份有限公司 | 芳基含氮杂环化合物、药物组合物和应用 |
| TW202521512A (zh) | 2023-07-31 | 2025-06-01 | 美商美國禮來大藥廠 | Kv1.3鉀shaker通道阻斷劑之固體形式及其使用方法 |
| CN121941688A (zh) * | 2023-10-09 | 2026-04-28 | 浙江海正药业股份有限公司 | 多取代芳基类衍生物及其制备方法和用途 |
| WO2025161144A1 (zh) * | 2024-01-29 | 2025-08-07 | 上海深势唯思科技有限责任公司 | 芳基杂环类Kv1.3抑制剂及其制备方法和用途 |
| WO2026021011A1 (zh) * | 2024-07-26 | 2026-01-29 | 浙江海正药业股份有限公司 | 芳基三环类衍生物及其制备方法和用途 |
| WO2026025999A1 (zh) * | 2024-08-01 | 2026-02-05 | 浙江海正药业股份有限公司 | 6,7-二氢-5H-吡咯并[1,2-a]咪唑类衍生物及其制备方法和用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2950479A1 (de) * | 1979-12-14 | 1981-06-19 | A. Nattermann & Cie GmbH, 5000 Köln | N-(3-alkylamino-2-hydroxypropoxy-phenyl)-lactame, deren herstellungsverfahren und arzneimitttel auf deren basis |
| JPH07309837A (ja) * | 1993-04-28 | 1995-11-28 | Takeda Chem Ind Ltd | ピリジン誘導体、その製造法および剤 |
| JPH09278757A (ja) * | 1996-04-15 | 1997-10-28 | Takeda Chem Ind Ltd | ヒドラゾン誘導体および剤 |
| TW467902B (en) * | 1996-07-31 | 2001-12-11 | Bristol Myers Squibb Co | Diphenyl heterocycles as potassium channel modulators |
| JP2002501912A (ja) * | 1998-01-29 | 2002-01-22 | ブリストル−マイヤーズ スクイブ カンパニー | ジアリール１、３、４−オキサジアゾロンのベンゾエート誘導体 |
| JP2004520348A (ja) * | 2001-01-15 | 2004-07-08 | グラクソ グループ リミテッド | Ｌｄｌ−受容体発現のインデューサーとしてのアリールピペリジン誘導体 |
| US7223788B2 (en) * | 2003-02-14 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
| US7384930B2 (en) * | 2004-11-03 | 2008-06-10 | Bristol-Myers Squibb Company | Constrained compounds as CGRP-receptor antagonists |
| CN101888989A (zh) * | 2007-10-04 | 2010-11-17 | 生态学有限公司 | 新型芳基钾通道阻断剂及其应用 |
| GB0815784D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0909672D0 (en) * | 2009-06-04 | 2009-07-22 | Xention Discovery Ltd | Compounds |
| WO2011073269A1 (en) * | 2009-12-16 | 2011-06-23 | Evotec Ag | Piperidine aryl sulfonamide derivatives as kv1.3 modulators |
| WO2017058716A1 (en) * | 2015-09-28 | 2017-04-06 | Vivace Therapeutics, Inc. | Tricyclic compounds |
| GB201610055D0 (en) * | 2016-06-09 | 2016-07-27 | Galapagos Nv And Laboratoires Servier Les | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis |
| GB201610056D0 (en) * | 2016-06-09 | 2016-07-27 | Galapagos Nv And Laboratoires Servier Les | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis |
| CN109705033B (zh) * | 2019-01-22 | 2021-03-30 | 杭州壹瑞医药科技有限公司 | N-杂芳基磺酰胺类衍生物及制备和应用 |
-
2020
- 2020-10-06 AU AU2020362108A patent/AU2020362108A1/en not_active Abandoned
- 2020-10-06 IL IL291868A patent/IL291868A/en unknown
- 2020-10-06 MX MX2022004127A patent/MX2022004127A/es unknown
- 2020-10-06 CN CN202080084663.XA patent/CN114746151A/zh active Pending
- 2020-10-06 JP JP2022546587A patent/JP2022550640A/ja not_active Withdrawn
- 2020-10-06 EP EP20874180.1A patent/EP4041407A4/en active Pending
- 2020-10-06 BR BR112022006202A patent/BR112022006202A2/pt not_active IP Right Cessation
- 2020-10-06 WO PCT/US2020/054347 patent/WO2021071802A1/en not_active Ceased
- 2020-10-06 US US17/766,832 patent/US20230026611A1/en active Pending
- 2020-10-06 CA CA3156980A patent/CA3156980A1/en active Pending
- 2020-10-06 KR KR1020227013513A patent/KR20220079882A/ko not_active Withdrawn
-
2025
- 2025-08-20 JP JP2025136895A patent/JP2025186255A/ja active Pending